Skip to main content

Table 6 Key baseline characteristics of participants for all individuals and by study group

From: The Reversal Intervention for Metabolic Syndrome (TRIMS) study: rationale, design, and baseline data

Characteristics

n

All

(n = 82)

n

Intervention

(n = 42)

n

Control

(n = 40)

p value

(I vs. C)

Demographic characteristics

       

Age (yrs)

82

63 [57 - 67]

42

65 [55 - 68]

40

62 [58 - 67]

p = 0.831

Sex: Male

82

36 (43.9)

42

21 (50.0)

40

15 (37.5)

p = 0.359

Ethnicity:

82

 

42

 

40

 

p = 0.268

South Asian

 

18 (22.0)

 

11 (26.2)

 

7 (17.5)

 

White

 

62 (75.6)

 

31 (73.8)

 

31 (77.5)

 

Other

 

2 (2.4)

 

0 (0.0)

 

2 (5.0)

 

IMD score (2007)

82

19.50 [14.04 - 33.74]

42

21.49 [14.04 - 21.49]

40

18.59 [13.55 - 32.96]

p = 0.344

NS-SEC-5 class:

82

 

42

 

40

 

p = 0.708

1

 

17 (20.7)

 

9 (21.4)

 

8 (20.0)

 

2

 

19 (23.2)

 

7 (16.7)

 

12 (30.0)

 

3

 

10 (12.2)

 

6 (14.3)

 

4 (10.0)

 

4

 

15 (18.3)

 

8 (19.0)

 

7 (17.5)

 

5

 

21 (25.6)

 

12 (28.6)

 

9 (22.5)

 

Measures related to MetS

       

Waist circumference(cm)

82

105.5 ± 10.8

42

103.9 ± 10.2

40

107.2 ± 11.2

p = 0.161

Systolic BP (mmHg)

82

132.4 ± 15.4

42

134.9 ± 13.2

40

129.8 ± 17.3

p = 0.139

Diastolic BP (mmHg)

82

85.9 ± 9.5

42

85.6 ± 9.7

40

86.1 ± 9.5

p = 0.803

HDL cholesterol (mmol/l)

82

1.20 [1.00 - 1.50]

42

1.20 [1.00 - 1.53]

40

1.20 [1.03 - 1.48]

p = 0.367

Triglycerides(mmol/l)

82

1.60 [1.20 - 2.00]

42

1.45 [0.98 - 1.93]

40

1.60 [1.40 - 2.08]

p = 0.112

FPG (mmol/l)

82

5.21 ± 0.56

42

5.23 ± 0.44

40

5.19 ± 0.66

p = 0.714

Proportion meeting IDF criteria for:

       

BP

82

73 (89.0)

42

37 (88.1)

40

36 (90.0)

p = 1.000

FPG

82

22 (26.8)

42

12 (28.6)

40

10 (25.0)

p = 0.908

HDL

82

72 (87.8)

42

35 (83.3)

40

37 (92.5)

p = 0.313

Triglycerides

82

67 (81.7)

42

35 (83.3)

40

32 (80.0)

p = 0.917

Total n° of IDF criteria met:

82

 

42

 

40

 

p = 0.924

3

 

25 (30.5)

 

13 (31.0)

 

12 (30.0)

 

4

 

44 (53.7)

 

23 (54.8)

 

21 (52.5)

 

5

 

13 (15.9)

 

6 (14.3)

 

7 (17.5)

 

Other bio-medical measures

       

BMI (kg/m 2 )

82

30.2 [28.1 - 33.1]

42

29.3 [27.8 - 32.2]

40

30.9 [28.8 - 34.1]

p = 0.140

Total cholesterol (mmol/l)

82

4.99 ± 0.86

42

4.82 ± 0.77

40

5.17 ± 0.93

p = 0.067

LDL cholesterol (mmol/l)

80

2.92 ± 0.74

42

2.80 ± 0.68

38

3.05 ± 0.80

p = 0.126

HbA1c (mmol/l)

80

42.0 [40.0 - 43.0]

40

41.0 [39.0 - 42.8]

40

42.5 [40.0 - 44.0]

p = 0.179

2 hour glucose (mmol/l)

81

5.80 ± 1.65

41

5.65 ± 1.43

40

5.95 ± 1.85

p = 0.419

Lifestyle & well being

       

Current smoker: yes

82

10 (12.2)

42

4 (9.5)

40

6 (15.0)

p = 0.514

Fruit & vegetables (portions/day)

82

3.0 [2.0 - 4.0]

42

3.0 [2.0 - 4.0]

40

3.0 [2.0 - 5.0]

p = 0.429

Pedometer counts (av steps/day)

72

5762 [3365 - 8592]

39

6829 [3224 - 8596]

33

4774 [3522 - 8653]

p = 0.705

EQ-5D score

82

0.80 [0.72 - 1.00]

42

0.80 [0.73 - 1.00]

40

0.76 [0.69 - 1.00]

p = 0.293

EQ-5D VAS

81

80.0 [70.0 - 90.0]

41

80.0 [70.0 - 90.0]

40

80.0 [ 61.3 - 90.8]

p = 0.420

  1. Parametric continuous data are expressed as mean ± S.D; nonparametric continuous data as median [IQR]; categorical data as number (%).
  2. Other ethnicity category: 1 Caribbean Indian, 1 mixed Caribbean/White British. NS-SEC-5 class: 1 (Managerial & professional occupations); 2 (Intermediate occupations); 3 (Small employers & own account workers); 4 (Lower supervisory & technical occupations); 5 (Semi-routine & routine occupations).
  3. IMD score: greater scores indicate a higher level of deprivation.
  4. Abbreviations: IMD (Index of Multiple Deprivation); NS-SEC (National Statistics Socio-economic Classification); BP (blood pressure); HDL (high density lipoprotein cholesterol); FPG (fasting plasma glucose); IDF (International Diabetes Federation); BMI (body mass index); LDL (low density lipoprotein ); HbA1c (glycated haemoglobin); EQ-5D (EuroQol EQ-5D); VAS (visual analogue scale).
Back to article page

Trials

ISSN: 1745-6215